相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Second allogeneic hematopoietic cell transplantation for relapse after first allografts
Boglarka Gyurkocza et al.
LEUKEMIA & LYMPHOMA (2019)
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT
Avichai Shimoni et al.
BLOOD CANCER JOURNAL (2019)
Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience
Hassan A. Aljasem et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions
Guillermo Orti et al.
EXPERIMENTAL HEMATOLOGY (2018)
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
Mohamed A. Kharfan-Dabaja et al.
JAMA ONCOLOGY (2018)
Acute Myeloid Leukemia, Version 3.2017
Margaret R. O'Donnell et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
Philip H. Imus et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes
R. Vrhovac et al.
BONE MARROW TRANSPLANTATION (2016)
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Espanol de Trasplante Hematopoyetico
Guillermo Orti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia
Monzr M. Al Malki et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
Hasan Sami Goksoy et al.
TRANSFUSION AND APHERESIS SCIENCE (2016)
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia
L. M. Poon et al.
BONE MARROW TRANSPLANTATION (2013)
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change
Maximilian Christopeit et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia
C Hosing et al.
BONE MARROW TRANSPLANTATION (2005)
Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: Outcome of 16 patients in a single institution
A Tomonari et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation
A Bosi et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant
IW Blau et al.
BONE MARROW TRANSPLANTATION (2000)